Press Releases :: Lexaria Bioscience Corp. (LEXX)

Jun 02, 2022 9:05am EDT

Lexaria Grants License to Valcon Medical for the European Market

Jun 01, 2022 9:00am EDT

Lexaria Announces 2022 Annual Meeting Results

May 26, 2022 8:30am EDT

Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands as Global Leader in Delivery Tech Space

May 25, 2022 8:30am EDT

Lexaria Bioscience Corp. (NASDAQ: LEXX) Offers Breakthrough Delivery Tech in Hot Nicotine Space

Apr 21, 2022 9:05am EDT

Lexaria Granted Patent for Use of DehydraTECH to Deliver Antiviral Drugs

Apr 19, 2022 9:05am EDT

Lexaria Commences Multi-Week Human Clinical Hypertension Study

Apr 14, 2022 8:45am EDT

Lexaria's Pulmonary Hypertension Clinical Study HYPER-H21-3 Delivers Positive Results

Apr 12, 2022 9:10am EDT

Lexaria Provides Update on Human Nicotine Study NIC-H22-1

Apr 11, 2022 9:00am EDT

Lexaria Begins New Nicotine Formulation Creation and Evaluation Program

Mar 15, 2022 2:05pm EDT

Lexaria Begins DehydraTECH-CBD Epilepsy Research Program

rss_feed News RSS